Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06092346 · ClinicalTrials.gov registry record
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
A clinical trial of AMPD3, OMIM*102772, AMP Deaminase Deficiency and AK1, OMIM *103000, Adenylate Kinase Deficiency, sponsored by National Human Genome Research Institute (NHGRI).
- Recruiting
- Registry status
- 999
- Enrollment target
- 1
- Study location
NCT06092346 is a study of AMPD3, OMIM*102772, AMP Deaminase Deficiency and AK1, OMIM *103000, Adenylate Kinase Deficiency that is actively recruiting participants, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 999 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06092346, a study of AMPD3, OMIM*102772, AMP Deaminase Deficiency and AK1, OMIM *103000, Adenylate Kinase Deficiency, is actively recruiting participants, sponsored by National Human Genome Research Institute (NHGRI).
- RECRUITING
- Registry status
- 999 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Pyrimidine and purine metabolism disorders (DPPMs) affect how the body metabolizes chemicals called pyrimidines and purines. DPPMs can cause dysfunctions throughout the body, especially in the brain, blood, kidneys, and immune system. People with DPPMs might have no symptoms, mild symptoms, or they may have severe, chronic symptoms, that can be fatal. DPPMs are not well understood, and researchers want to learn more about what causes them and how to treat them. Objective: To learn more about factors that affect DPPMs by comparing test results from affected, uaffected family members, and healthy people. Eligibility: Three types of participants are needed: people aged 1 month and older with DPPMs; their family members who do not have DPPMs; and healthy volunteers. Design: Participants with DPPMs will come to the clinic once a year; some may be asked to come more often. At each visit, all affected participants will have a physical exam and give samples of blood, urine, saliva, and stool. Depending on their symptoms, they may also have other procedures, such as: Swabs of their skin and inside the mouth. Tests of their heart, kidney, brain, and nerve function. Questionnaires about what they eat. Dental exams, and exams of their hearing and vision. Tests of their learning ability. Monitoring of their physical activity. Imaging scans. Photographs of their face and body. These tests may be spread over up to 7 days. Affected participants may remain in the study indefinitely if they wish to. Healthy volunteers and family members will have 1 study visit. They will have a physical exam and may be asked to give blood, urine, saliva, and stool samples.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 999 participants |
| Start Date | 2023-12-19 |
| Est. Completion | 2099-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06092346
The ClinicalTrials.gov registry entry for NCT06092346 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 999 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with AMPD3, OMIM*102772, AMP Deaminase Deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT06092346 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06092346 about?
NCT06092346 is a clinical study titled "A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders". Background: Pyrimidine and purine metabolism disorders (DPPMs) affect how the body metabolizes chemicals called pyrimidines and purines. DPPMs can cause dysfunctions throughout the body, especially in the brain, blood, kidneys, and immune system. People with DPPMs might have no symptoms, mild sympt...
What is the current status of trial NCT06092346?
This trial is currently recruiting. The enrollment target is 999 participants. The study started on 2023-12-19. Estimated completion is 2099-01-01.
What conditions does trial NCT06092346 study?
This clinical trial studies the following conditions: AMPD3, OMIM*102772, AMP Deaminase Deficiency, AK1, OMIM *103000, Adenylate Kinase Deficiency, AMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency, TPMT, OMIM *187680, Thoipurines, Poor Metabolism of, IMPDH1, OMIM *146690, Retinitis Pigmentosa Type 10, Leber Congenital Amauriosis Type 11.
Who is sponsoring clinical trial NCT06092346?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06092346 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
AMPD3, OMIM*102772, AMP Deaminase Deficiency
All registered trials for this condition
AK1, OMIM *103000, Adenylate Kinase Deficiency
All registered trials for this condition
Maryland
All trials with a study site in Maryland
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.